HANXBIO-B

3378
23.1405.86% ( -1.440 )
Delay Midday Break: Nov 17, 11:51:42

Shareholders

All Shareholders

Shareholder Type

  • Private companies79.49%
  • Public and others12.05%
  • Public companies4.72%
  • Institutions2.32%
  • Individuals & Insiders1.43%

Major Shareholders

Major Shareholders Latest
Shareholder
Cai Zhang Biotechnology (Hangzhou) Co., Ltd
40.60%55.30M0.00%+0
Hanx Biopharmaceuticals (HK) Limited
13.06%17.79M0.00%+0
Hangzhou Hongye Ruiji Investment Partnership (Limited Partnership)
9.44%12.86M0.00%+0
Beijing Lapam Biopharmaceutical Venture Capital Center (Limited Partnership)
9.44%12.86M0.00%+0
Betta Pharmaceuticals Co., Ltd.
4.72%6.43M0.00%+0
Wuhan Donggaorensi Equity Investment Partnership (Limited Partnership)
2.51%3.42M0.00%+0
Wuhan Hanx Tai Management Consulting Partnership (L.P.)
2.24%3.05M0.00%+0
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)
1.88%2.56M0.00%+0
Yangtze Investment (HK) Limited
1.32%1.80M0.00%+0
Qixiang LiCEO, CSO, GM & Executive Director
1.00%1.37M0.00%+0
Tibet Lapam Small and Medium Enterprise Development Fund Equity Investment Partnership (Limited Part
0.88%1.20M0.00%+0
Lapam Capital
0.44%596.04K0.00%+0
Min LiuCOO, Vice GM & Executive Director
0.40%546.57K0.00%+0
Liao Tong
0.02%21.35K0.00%+0
Jieyu XiaoCFO, Secretary of the Board & Executive Director
<0.01%11.10K0.00%+0
Zou Zhiyong
<0.01%1.71K0.00%+0